(B) Representative H&E staining and immunohistochemistry of tumor

(B) Representative H&E staining and immunohistochemistry of tumors derived from intracranial xenografts of glioma cells.aL-dL(low magnification images)L and a-d(high magnification images), HE staining of tumors derived from intracranial xenografts of glioma cells. e-h, GFAP immunohistocheistry Ribociclib manufacturer of tumors derived from intracranial xenografts of glioma cells. i-l, CD34 immunohistocheistry

of tumors derived from intracranial xenografts of glioma cells. (a, e, i, U251-AAV. b, f, j, U251-AAV-IB. c, g, k, SF763-si-control. d, h, l, SF763-si-IB). Magnification was ×20 in a-d, and ×40 in e-l. (C) Survival of animals intracranially injected with glioma cells that were infected or knocked down using BMPR-IB and control vectors (log

rank test: p < 0.0001). Next, to study the growth of these glioma cells in the brain, we used a xenograft model of human glioma, in which we injected glioma cells intracranially into nude mice. As with the subcutaneously injected cells, intracranially injected U251-AAV cells (1×107 per mouse) formed invasive brain tumors that presented characteristic glioblastoma features, including nuclear pleomorphism, prominent mitotic activity, and highly invasive behavior (Figure 6B). These tumor masses also exhibited microvascular proliferation characterized by a substantially increased number of CD34-positive microvessels selleck chemicals llc (Additional file 1: Figure S 4). Intracranial injection of U251-AAV-IB cells (1× 107 per mouse) did not result in the formation of invasive

tumors; instead, small, delimited lesions confined to the injection site were observed 90 days after injection. Immunohistology showed that these tumor masses presented a more mature morphology than that in control groups, characterized by the increased expression of GFAP, and less ventricular invasion. Furthermore, Kaplan–Meier survival analysis showed that BMPR-IB overexpression significantly extended the survival time of the mice compared with the controls (P < 0.0001; Figure 6B, C). Conversely, SF763 si-control infected cells did not produce tumors intracalvarially in injected mice; however, the SF763-Si-BMPR-IB cells produced invasive brain tumors intracalvarially, which resulted in decreased Tacrolimus (FK506) overall survival time compared with controls (P < 0.0001, Figure 6B, C). Discussion Although several studies have suggested that BMPR-IB plays an important role in the development of some solid tumors, such as prostate cancer and breast cancer [14, 15], its role and associated molecular mechanisms related to the development of glioma are not completely understood. In our study, we found both clinical and experimental evidence that aberrant BMPR-IB expression critically regulates the tumorigenicity of human glioma cells in vitro and in vivo [5].

brasiliensis presented leukocytosis at days 20 and 60 after infec

brasiliensis presented leukocytosis at days 20 and 60 after infection (Fig. 4A). On the 20th day of infection, lymphocytes and neutrophils were the predominant cells whereas on the subsequent days, although lymphocytes remained the major cell population, monocytes surpassed neutrophils (Fig. 4B). A peak of eosinophil numbers was detected on the 20th day,

progressively decaying thereafter. Figure 4 Leukocyte levels in the blood of Calomys callosus during infection with Paracoccidioides brasiliensis. A – Each point represents the mean ± standard deviation of counts of total leukocytes in blood samples from 4 animals. B – Absolute numbers of neutrophils, lymphocytes, and monocytes. C – Absolute numbers of eosinophils. Effect of P. brasiliensis infection on glucose blood selleck kinase inhibitor levels of C. callosus Based on the observations that the pancreas was seriously compromised throughout infection, we questioned whether this fact could affect ICG-001 mw the serological glucose levels of C. callosus. As shown in Fig. 5, infected animals start to loose control of glucose levels after 60 days of infection, when serum levels drop as the infection progresses. Figure 5 Serum glucose

in Calomys callosus during infection with 1 × 10 6 yeast forms of Paracoccidioides brasiliensis. Bars represent the mean and standard deviation of 4–5 animals per group. * Statistically different from controls, ANOVA, T test, p < 0.05. Effect of ovariectomy on P. brasiliensis infection of C. callosus It has been shown

that estrogen hormone is one of the P. brasilensis infection resistance mechanisms [19]. In order to understand the estrogen role in the C. callosus infection, infected ovariectomized animals were compared to sham-operated many animals. The infection progression in sham-operated animals developed similarly as in non-operated animals (Fig. 1 and data not shown). The lesions observed in ovariectomized animals showed that the infiltrate contained fewer inflammatory cells and that the parenchyma of the liver (Fig. 6A, C and 6E) and spleen (Fig. 6B and 6D) were damaged. The inflammatory lesions seen in the liver of ovariectomized animals were concentrated in the space of Dissé until the 45th day of infection (Fig. 6A and 6C). A fewer number of yeast debris were observed in ovariectomized infected animals compared to sham-operated infected animals, throughout the study (Fig. 6). At day 75, a diffuse mononuclear infiltration was observed in the liver although with very few intact parasites. As early as 15 days post infection, a neutrophil infiltrate was observed in the spleen (Fig. 6B) that was not seen later on infection (Fig. 6D). Figure 6 Histological analyses of female Calomys callosus infected i.p. with Paracoccidioides brasiliensis after bilateral ovariectomy. The tissue sections stained with haematoxylin-eosin were examined at a magnification of 200 X.

Conclusion The results presented in this work demonstrate a clear

Conclusion The results presented in this work demonstrate a clear, dose dependent cytotoxic and antiviral effect of resveratrol: cytotoxicity at high concentration of the drug both on normal and tumor cells. On the other hand at low concentration, the continuous presence in the culture medium is necessary for the drug to be effective. The target of RV is the replication of viral DNA; however further studies are required for the full elucidation of the inhibitory mechanism mediated by RV leading to

the abrogation of the viral DNA synthesis. This effect was demonstrated in the absence of significant cytotoxic effects induced by the check details drug. Removal of RV at short time after infection does not have a significant effect on the production of viral progeny DNA and this suggests that the viral

penetration is not the main target of the drug. Therefore we may conclude that the RV dependent inhibition of the viral proliferation occurs at subsequent stages: possibly during translocation of the virion from cytoplasm to nucleus. Finally this work gives a further support to the possibility that RV may find a potential clinical use for the control of proliferative pathologies and/or as an antiviral drug. Acknowledgements Financial support by the Italian Ministry of Education and Sigma-Tau is acknowledged (grants Erlotinib mw to GR). The collaboration of Michela Di Nottia in performing some experiments is also acknowledged. The graphic elaboration of the figures by Riccardo Risuleo is also acknowledged. References

1. Tooze J, (Editor): Molecular biology of tumor viruses: DNA Tumor Viruses. second edition. Cold Spring Harbor Laboratory Press, New York, USA; 1982. 2. Howley PM, Livingston DM: Small DNA tumor viruses: large contributors to biomedical sciences. Virology 2009, 384: 256–9.CrossRefPubMed 3. Yaniv M: Small DNA tumour viruses and their contributions to our understanding of transcription control. Virology 2009, 384: 369–374.CrossRefPubMed 4. Moens U, Johannessen M: Human polyomaviruses and cancer: expanding enough repertoire. J Dtsch Dermatol Ges 2008, 6: 704–708.CrossRefPubMed 5. Jiang M, Abend JR, Johnson SF, Imperiale MJ: The role of polyomaviruses in human disease. Virology 2009, 384: 266–73.CrossRefPubMed 6. zur Hausen H: Novel human polyomaviruses – re-emergence of a well known virus family as possible human carcinogens. Int J Cancer 2008, 123: 247–250.CrossRefPubMed 7. Khalili K, Sariyer IK, Safak M: Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation. J Cell Physiol 2008, 215: 309–319.CrossRefPubMed 8. Iacoangeli A, Melucci-Vigo G, Risuleo G: Mechanism of the inhibition of murine polyomavirus DNA replication induced by the ionophore monensin. Biochimie 2000, 82: 35–39.CrossRefPubMed 9.

These sensors were purchased from Vernier (Beaverton,

These sensors were purchased from Vernier (Beaverton, Selleck Rapamycin OR). A double bagging system was used to avoid air leaks during the measurements taken with the O2 sensors during incubation. Changes in O2 concentration were measured in all subsamples. The O2 Gas Sensor was calibrated to the environment within the plastic bag which produces condensation (100% humidity), and therefore

was started at 20.1 O2 in percentage by volume. The DO sensor was positioned in the enrichment bag with the collection tip of the sensor placed at the bottom of the enrichment broth with the subsample. The O2 sensor was placed in the head space of the bag above the liquid. The excess air was expelled from the bag before sealing and incubation for 48 h. The DO sensor was calibrated by pre-warming the probe for 10 min in the broth before starting the readings. Throughout incubation, the sensors were connected to a laptop computer with the Logger Lite™ data collection program (version 1.4) that recorded readings every 1 min. The data were analyzed using

Microsoft Excel (Microsoft Corporation, Redmond, WA). Statistical analyses An unpaired sample design was used where the number of Campylobacter positive subsamples enriched under microaerobic conditions (reference method) was compared to the number of Campylobacter positive subsamples enriched under aerobic conditions Bcl-2 inhibitor (alternative method). Statistical comparisons were made using the formula mcnemar. test (x, y, correct = TRUE) of R [41], which is the McNemar’s chi-squared (γ2) test for count data, and it is based on McNemar’s Test for correlated proportions [42]. The accuracy, sensitivity, specificity,

and Kappa values for the test were calculated using 2-by-2 tables according to Hanrahan and Madupu [43]. A receiver operating characteristic (ROC) curve was determined with a web-based calculator with an ordinal rating scale of 1 through 4, where 1 represents samples that were negative Decitabine for Campylobacter spp. in both subsamples, and 4 represents samples that were positive for both subsamples [44]. Acknowledgements We thank Leslie Speegle for her assistance in collecting the sensor data and Kennedy Wekesa for allowing us access to the phase contrast microscope. JK work was supported by grant 0754966 from the Research Experiences for Undergraduates Program of the Biology Directorate of the National Science Foundation. The work of S.B. is supported by Science Foundation Ireland (UCD 09/IN.1/B2609). References 1. Anon: European Food Safety Authority. Trends and sources of zoonoses, zoonotic agents and antimicrobial resistance in the European Union in 2004 2006, 96–16. 2. Anon: Isolation, identification, and enumeration of Campylobacter jejuni / coli / lari from poultry rinse and sponge samples. [http://​www.​fsis.​usda.​gov/​PDF/​MLG_​41_​01.​pdf] Laboratory Guidebook, MLG 41.

JL: Study conception and design, acquisition of data,

JL: Study conception and design, acquisition of data, check details analysis and interpretation of data, drafting of manuscript. SF: Acquisition of data, analysis and interpretation of data, drafting of manuscript. MH: Study conception and design, analysis and interpretation of data, drafting of manuscript. FH: Study conception and design, analysis and interpretation of data, critical revision. EV: Analysis and interpretation of data, critical revision of manuscript. LL: Study conception and design, critical revision of manuscript. All authors have given

final approval for this manuscript to be published.”
“Introduction Colorectal cancer (CRC) is one of the common cancers in which surgery plays a crucial RXDX-106 clinical trial role in the definitive management. When a diagnosis of CRC is suspected, it is recommended by the UK National Health Service that the patient should be referred within 2 weeks [1] and treatment should be performed within one month of diagnosis [2]. However, due to resource constraints, this quick response is often impossible [3], resulting in 15-30% of CRC cases require emergency surgery due to development of acute symptoms while they await their surgery [4]. Identifying CRC patients who are likely to develop acute conditions in order to have the option of considering

fast-track service could reduce problems associated with prolonged waits for necessary surgeries. Unplanned operations in patients with colorectal cancer are associated with a higher incidence of operative complications and poorer

surgical outcome than non-emergency procedures [4–6], and the most common condition that leads to emergency surgery in these patients is colonic obstruction [7]. CRC patients that are at risk of Thiamet G needing emergency surgery should, therefore, be prioritized. However, the clinical presentation of CRC patients is not always correlated with the severity of obstruction, this making the scheduling of prioritized surgeries a hit-and-miss decision at best. In this study, we aimed to look for a correlation between an endoscopic finding of tumor obstruction and the risk of needing emergency surgery in CRCs. Methods Histologically proven colorectal adenocarcinoma patients recorded in the Cancer Registry Unit of Songklanagarind Hospital who were operated on at the institute during the period between the years 2002 and 2011 and who had a colonoscopy before their operation were included in this retrospective review. The data were retrieved from electronic medical records and reviewed regarding clinical and pathological parameters with an emphasis on the management timeline.

The results are the opposite of

what would be expected fr

The results are the opposite of

what would be expected from substrate studies. As mentioned previously, the proteomics shows an increase in the aspartate/asparagine pathway and a reduction in glutamate/glutamine. Culture growth studies found that P. gingivalis grown on aspartylaspartate had significantly more butyrate production than propionate compared to cultures grown on glutamylglutamate [13]. However, a recent flux balance model of P. gingivalis metabolism predicts that there is abundant flexibility in the production of butyrate, propionate and succinate with the metabolic routes to each being equivalent with respect to redox balancing and energy production [20]. Thus a shift towards propionate could be easily explained if it presented an advantage to internalized cells. In that regard, it has been shown that butyrate is a more potent apoptosis inducing agent than propionate GSI-IX [21]. Hence, the diminished production of butyrate by internalized P. gingivalis may contribute to the resistance of P.

gingivalis-infected GECs to apoptotic cell death [22]. There is also the question of the reduced abundance of glutamate BAY 80-6946 dehydrogenase (PGN1367), the protein that converts glutamate to 2-oxoglutarate (Fig. 2). If this is the primary substrate for propionate production it could limit that production even with increased abundance in the rest of the pathway. However, 2-oxoglutarate is a common metabolic intermediate and glutamate/glutamine may not be the only source of 2-oxoglutarate for propionate production. PRKACG Even if it is the primary source, given the flexibility in byproduct production, a significant shift away

from butyrate production from glutamate/glutamine to propionate production could still occur in the presence of an overall reduction in glutamate/glutamine usage. Interestingly, some similar shifts are seen between planktonic cells and biofilms of P. gingivalis strain W50. A mass spectrometry analysis of planktonic cells versus biofilm cells identified 81 proteins and found several energy metabolism proteins with significant differences between planktonic and biofilm lifestyles [23]. In biofilms fumarate reductase (PGN0497, 0498) had reduced abundance while oxaloacetate decarboxylase (PGN0351) had increased abundance similar to what we see in internalized cells (Fig. 2). Obviously, biofilms and the interior of GECs are different environments, and the energy metabolism protein glyceraldehyde-3-phosphate dehydrogenase (PGN0173) was increased in biofilms [23] relative to planktonic cells, while it is decreased in internalized cells relative to external controls. A comparison between the two conditions would really require the identification of more metabolic proteins from biofilm cells, but given the relevance of biofilm formation to P. gingivalis pathogeniCity in vivo [24–26], the relation between biofilm conditions and internalized cells is an interesting one that we intend to pursue further at the whole proteome level.

The exercise conditions that can induce muscle damage are unaccus

The exercise conditions that can induce muscle damage are unaccustomed exercise and exercise with higher intensity or longer duration than those to which the subject is adapted [38, 39]. Because a high number of concentric and, particularly, eccentric contractions are performed during long-distance running, the symptoms of muscle damage are usually observed immediately and a few days after a running bout even in experienced runners [40]. Our participants

included running exercise in their daily regular physical activity, and this may explain the modest increase Enzalutamide in vitro in CK activity compared to Hou et al. [21] data. An unaccustomed running duration may be the main reason for changes in CK activity and muscle power in our participants. The key components of DMW contributing to the observed ergogenic benefits are not known. In our study, the calcium–magnesium–sulfate DMW was taken from a depth of about 700 m

and is characterized by enriched LY294002 cost contents of boron, phosphorus, chromium, manganese, iron, and copper. Hou et al. [21] speculated that the effect of deep ocean water on accelerating recovery after fatigue may be associated with the attenuation of exercise-induced muscle damage. It has been found that the main supplements that seem to protect against muscle damage are the flavonoids, which are known for their efficient anti-inflammatory and antioxidant properties [41]. Howatson et al. [42] reported that runners who consumed Tolmetin tart cherry juice for 5 days before and 48 h after a marathon showed faster recovery of muscle

strength and reduced inflammation [42]. However DMW used in our study as well as deep ocean water do not contain such components. Possibly the minerals and trace elements in DMW may work cooperatively to restore normal human performance. Snell et al. [19] reported that recovery was significantly faster when consuming a rehydration drink containing fructose, glucose polymer, calcium, magnesium, sodium, potassium, amino acids, thiols, and vitamins compared with Crystal Light, while replenishment with Gatorade, which contains fructose, glucose, sodium and potassium [20]. It is possible that the different effects on performance between a rehydration drink and Gatorade may be associated with higher concentration of calcium and magnesium in the rehydration drink. This may explain the better recovery of performance in our study in the DMW trial because DMW is rich in calcium and magnesium. In animals, a lack of dietary magnesium leads to increased free radical production [43], and magnesium supplementation eliminates free radical production induced by ischemia– reperfusion [44] and alcohol consumption [45]. Serum magnesium concentration and dietary magnesium intake are known correlates of muscle strength [46, 47]. It has been recently shown that magnesium enhances glucose availability in the peripheral and central systems and increases lactates clearance in the muscle during exercise in rats [48]. Hou et al.

​htm Accessed 5 Dec 2012 4 Aubeny E, Buhler M, Colau JC, et al

​htm. Accessed 5 Dec 2012. 4. Aubeny E, Buhler M, Colau JC, et al. The Coraliance study: non-compliant behavior. Results after a 6-month follow-up of patients on oral contraceptives. Eur J Contracept Reprod Health Care. 2004;9(4):267–77.PubMedCrossRef 5. Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric. selleck compound 2005;8(Suppl 1):3–63.PubMedCrossRef 6. Goldzieher JW, Brody SA. Pharmacokinetics of ethinyl estradiol and mestranol. Am J Obstet Gynecol. 1990;163(6 Pt 2):2114–9.PubMedCrossRef 7. Jung-Hoffmann C, Kuhl H. Intra- and interindividual variations in contraceptive steroid

levels during 12 treatment cycles: no relation to irregular bleedings. Contraception. selleck screening library 1990;42(4):423–38.PubMedCrossRef 8. Burkman RT. Transdermal hormonal contraception: benefits and risks. Am J Obstet Gynecol. 2007; 197(2):134.e1–6. 9. Coelingh Bennink HJ. Are all estrogens the same? Maturitas. 2004;47(4):269–75.PubMedCrossRef 10. Wilde MI, Balfour JA. Gestodene: a review of its pharmacology, efficacy and tolerability in combined contraceptive

preparations. Drugs. 1995;50(2):364–95.PubMedCrossRef 11. Kaplan B. Desogestrel, norgestimate, and gestodene: the newer progestins. Ann Pharmacother. 1995;29(7–8):736–42.PubMed 12. Barbosa IC, Filho CI, Faggion D Jr, Baracat EC. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse). Contraception. 2006;73(1):30–3.PubMedCrossRef 13. Heger-Mahn D, Warlimont C, Faustmann T, et al. Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers. Eur J Contracept Reprod Health Care. 2004;9(3):173–81.PubMedCrossRef 14. Benagiano G, Primiero FM, Farris M.

Clinical profile of contraceptive progestins. Eur J Contracept Reprod Health Care. 2004;9(3):182–93.PubMedCrossRef GNA12 15. Kuhl H, Jung-Hoffmann C, Wiegratz I. Gestodene-containing contraceptives. Clin Obstet Gynecol. 1995;38(4):829–40.PubMedCrossRef 16. Bitzer J, Simon JA. Current issues and available options in combined hormonal contraception. Contraception. 2011;84(4):342–56.PubMedCrossRef 17. Melis GB, Fruzzetti F, Nicoletti I, et al. A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors. Contraception. 1991;43(1):23–31.PubMedCrossRef 18. Committee for Medicinal Products for Human Use. Guideline on clinical investigation of steroid contraceptives in women. European Medicines Agency, London. 2005. http://​www.​emea.​europa.​eu/​docs/​en_​GB/​document_​library/​Scientific_​guideline/​2009/​09/​WC500003349.​pdf. Accessed 22 Feb 2013. 19. Winkler UH, Schindler AE, Endrikat J, Dusterberg B.

Conclusions Direct association of FliX and FlbD is required for t

Conclusions Direct association of FliX and FlbD is required for their regulation on flagellar synthesis and other developmental events in Caulobacter. FliX and FlbD form high affinity complexes under physiological conditions, which is essential for the in vivo stability of each protein. Highly conserved regions of FliX are critical for binding to FlbD. Mutations in these regions could severely impact the recognition between the two and compromise their regulatory activity. Acknowledgements We are grateful to Dr. Jill Zeilstra-Ryalls at BGSU for helpful discussions.

This work was supported by Public Health Service Grant GM48417 from the National Institutes of Health to JWG. References selleck chemical 1. Brun YV, Marczynski G, Shapiro L: The expression of asymmetry during Caulobacter cell differentiation. Annu Rev Biochem 1994, DAPT in vivo 63:419–450.PubMedCrossRef 2. Gober JW, England J: Regulation of flagellum biosynthesis and motility in Caulobacter Prokaryotic Development . Edited by: Brun KV, Shimkets LJ. Washington, DC: American Society for Microbiology; 2000:319–339. 3. Gober JW, Marques

MV: Regulation of cellular differentiation in Caulobacter crescentus. Microbiol Rev 1995,59(1):31–47.PubMed 4. Wu J, Newton A: Regulation of the Caulobacter flagellar gene hierarchy; not just for motility. Mol Microbiol 1997,24(2):233–239.PubMedCrossRef 5. England JC, Gober JW: Cell cycle control of cell morphogenesis in Caulobacter. Curr Opin Microbiol 2001,4(6):674–680.PubMedCrossRef 6. Bryan R, Purucker M, Gomes SL, Alexander Lepirudin W, Shapiro L: Analysis of the pleiotropic

regulation of flagellar and chemotaxis gene expression in Caulobacter crescentus by using plasmid complementation. Proc Natl Acad Sci USA 1984,81(5):1341–1345.PubMedCrossRef 7. Champer R, Dingwall A, Shapiro L: Cascade regulation of Caulobacter flagellar and chemotaxis genes. J Mol Biol 1987,194(1):71–80.PubMedCrossRef 8. Mangan EK, Bartamian M, Gober JW: A mutation that uncouples flagellum assembly from transcription alters the temporal pattern of flagellar gene expression in Caulobacter crescentus. J Bacteriol 1995,177(11):3176–3184.PubMed 9. Minnich SA, Newton A: Promoter mapping and cell cycle regulation of flagellin gene transcription in Caulobacter crescentus. Proc Natl Acad Sci USA 1987,84(5):1142–1146.PubMedCrossRef 10. Newton A, Ohta N, Ramakrishnan G, Mullin D, Raymond G: Genetic switching in the flagellar gene hierarchy of Caulobacter requires negative as well as positive regulation of transcription. Proc Natl Acad Sci USA 1989,86(17):6651–6655.PubMedCrossRef 11. Ohta N, Chen LS, Mullin DA, Newton A: Timing of flagellar gene expression in the Caulobacter cell cycle is determined by a transcriptional cascade of positive regulatory genes. J Bacteriol 1991,173(4):1514–1522.PubMed 12.

These responses are indicative of an up-regulation of intestinal

These responses are indicative of an up-regulation of intestinal calcium absorption and renal reabsorption of calcium, respectively [2, 12]. However,

further studies specifically designed to assess calcium economy in the intestine and kidney are needed to confirm these findings. The differences in the response to calcium loading and results of our previous studies of pregnant and lactating women from The Gambia may indicate that the adaptations in calcium homeostasis may be different for Western and Gambian women. On theoretical grounds and as shown in our earlier studies in this population [19], it may be expected that with a calcium intake of ~350 mg/day, Ku 0059436 calcium absorption and renal calcium reabsorption are near their selleck inhibitor physiological maximum to meet the requirements for obligatory calcium losses in urine and faeces and, additionally during the reproductive cycle, for foetal skeletal mineralisation, secretion into breast milk (~200–300 mg/day) and post-lactational maternal bone mineral accretion [3]. This is underpinned by the low urinary calcium losses in Gambian NPNL and pregnant women shown in this study and other studies in this population [7], and by the absence of or only a moderate decrease in, urinary calcium losses during lactation as measured in 24 h, fasting and post-loading urine collections (this

study; [7]). An alternative explanation for the absence of differences in the calcemic response between reproductive OSBPL9 stages is the length of lactation (up to 2 years) and the typically short interval between cessation of lactation and next conception in this population [7]. The NPNL women in this study

may therefore be in a different physiological state than those women included in other reports [1, 2] and may have a greater or more prolonged rate of calcium incorporation into the maternal skeleton in response to cessation of lactation. The three groups were matched for age and parity, and the NPNL women were eumenhorreic. It is, therefore, unlikely that the findings of the study reflect biological differences in the ability to conceive. Despite the apparent moderate differences in calcium homeostasis between pregnant and lactating Gambian women compared to the differences seen in Western women, our earlier studies have shown that the changes in bone mineral status in lactating Gambian mothers at 13 weeks post-partum are similar to those reported for breastfeeding mothers with higher calcium intakes [5, 7]. This is consistent with other findings that dietary calcium intake is not a predictor of the changes in maternal bone mineral status associated with lactation [3, 4]. The conservation of bone mineral may be partly explained by the lower calcium outputs in breast milk, as mean milk calcium concentrations from Gambian women are lower than those of British women [7, 20, 21].